Identification of wild‐type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS). (3rd October 2022)

• Record Type: Journal Article
• Authors: Ladefoged, Bertil; Clemmensen, Tor; Dybro, Anne; Hartig‐Andreasen, Charlotte; Kirkeby, Lone; Gormsen, Lars Christian; Bomholt, Peter; Gillmore, Julian; Poulsen, Steen Hvitfeldt
• Is Part Of: ESC heart failure. Volume 10:Number 1(2023)
• Page Start: 234
• Page End: 244
• Publication Date: 2022-10-03
• Subjects: Transthyretin cardiac amyloidosis -- Carpal tunnel syndrome -- Screening -- Echocardiography; Heart failure -- Periodicals; 616.129005
• DOI: 10.1002/ehf2.14173
• Languages: English
• ISSNs: 2055-5822

Abstract

Abstract: Aims: Wild‐type transthyretin cardiac amyloidosis (ATTRwt) is an infiltrative cardiomyopathy with a poor prognosis. The condition is associated with carpal tunnel syndrome (CTS), which often precedes the ATTRwt diagnosis by several years. The aim of the study was (i) to screen patients with a recent history of CTS for ATTRwt using red flags, (ii) to determine whether patients with screened ATTRwt had less advanced disease compared with patients with clinical ATTRwt, and (iii) to assess the sensitivity and specificity of known red flags in ATTRwt. Methods and results: Patients aged ≥60 years at the time of CTS surgery were invited for screening. Red flags were defined as elevated biomarker levels of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) or cardiac troponin, an electrocardiogram pattern associated with ATTRwt, left ventricular hypertrophy (LVH), and impaired longitudinal strain with apical sparring. All patients with a red flag were referred for a diagnostic scintigraphy. Patients with ATTRwt diagnosed by screening were compared with patients with clinical ATTRwt ( n = 51) matched by age, gender, and CTS surgery. Among the 120 enrolled subjects (mean age 74.5 years, 90% male), the suspicion of ATTR was raised in 67 (55.8%), and 10 (8.3%) were diagnosed with ATTRwt. Patients identified with ATTRwt were predominantly asymptomatic and had mildly elevated NT‐proBNP, mildly increased LVH, preserved left ventricular ejection fraction, and systolic longitudinal function, which differed significantly from clinical ATTRwt controls ( P < 0.001). Conclusions: The study found an ATTRwt prevalence of 8.3% in a population of age and gender‐selected patients with a recent history of CTS. The identified patients with ATTRwt had less structural and functional cardiac involvement than clinical ATTRwt controls.